Jaguar Health, Inc. (JAGX) vs Onconetix, Inc. (ONCO)
A side-by-side comparison of Jaguar Health, Inc. and Onconetix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
JAGX
Jaguar Health, Inc.
$5.84HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
ONCO
Onconetix, Inc.
$0.66HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
Total return — JAGX vs ONCO
growth of $100 · dividends reinvested · last 3yJAGX -100.0% (-92.6%/yr)ONCO -100.0% (-96.7%/yr)JAGX compounded faster over this window
Log scale — wide-divergence pair
JAGX ONCO
JAGX vs ONCO: by the numbers
- •JAGX is the larger company ($3M vs $2M market cap).
- •Both run net losses; JAGX's is the smaller (-131.76% vs -1578.79% net margin).
Metrics side by side
Valuation
| Metric | JAGX | ONCO |
|---|---|---|
| P/S ratio | 0.09 | 3.68 |
| P/B ratio | 0.38 | 0.18 |
Profitability
| Metric | JAGX | ONCO |
|---|---|---|
| Gross margin | 67.21% | 80.40% |
| Operating margin | -391.87% | -778.16% |
| Net margin | -131.76% | -1578.79% |
| ROE | -554.01% | -75.70% |
| ROIC | -110.81% | -59.84% |
Growth (annualized)
| Metric | JAGX | ONCO |
|---|---|---|
| Revenue CAGR (5Y) | 31.88% | N/A |
Go deeper
Dig into the metrics
Jaguar Health ROEOnconetix ROEJaguar Health operating marginOnconetix operating marginJaguar Health revenue growthOnconetix revenue growthJaguar Health free cash flowOnconetix free cash flow
Jaguar Health & Onconetix appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.